跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
K562-S
首页
药物
K562-S
K562-S
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
APPLICATION OF THYROID HORMONE AND ANALOGUE THEREOF IN PREPARATION OF DRUG FOR TREATING SICKLE-CELL DISEASE
WO 2021208551 A1
申请人: RUIJIN HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
优先权: 2020
CN
WO
2 件公开
Synthesis and application of novel s-guaiazulene sesquiterpenoid alkaloids
CN 110041246 A
申请人: OCEAN UNIV CHINA
优先权: 2018
CN
一种跨膜表达新型冠状病毒抗原的细胞的制备方法、细胞和应用
CN 112251413 B
申请人: 焦顺昌
优先权: 2020
CN
一类含二唑、三唑及吡唑结构单元的吲哚衍生物及其应用
CN 113754649 B
申请人: 贵州大学
优先权: 2021
CN
CD38-targeted polypeptide, ligand thereof, coupled drug and application of CD38-targeted polypeptide and ligand thereof
CN 121319117 A
申请人: ZHULIUYUAN BIOTECHNOLOGY SHANGHAI CO LTD
优先权: 2025
CN
Targeted protein degradation agent utilizing ubiquitin-proteasome pathway as well as preparation method and application of targeted protein degradation agent
CN 121930214 A
申请人: FIRST AFFILIATED HOSPITAL MEDICAL COLLEGE XIAN JIAOTONG UNIV
优先权: 2026
CN
药物
反馈